AbbVie is on the rebound after a sell-off on concerns about the pending FDA decision for a biosimilar drug. Humira and Enbrel are among the top-selling drugs to be copycatted but biosimilars are ...

A Colorado panel voted Friday to cap the price for a best-selling drug from Amgen. It is one of four states that have passed legislation allowing price caps for specific prescriptions.

(Reuters) - Amgen Inc's version of AbbVie Inc's Humira arthritis drug, the world's top-selling medicine, appears similar in potency and safety to the original product, U.S. Food and Drug ...

The financial future of pharmacy benefit managers is uncertain as payers, legislators and regulators focus on rising drug prices, according to Moody's Investors Service. The rising price of drugs such ...

LONDON, March 15 (Reuters) - Abbott Laboratories' drug Humira and Enbrel, from Pfizer and Amgen , should be the first choices for treating patients with psoriatic arthritis, Britain's ...

Abbott Laboratories, which received a surprisingly quick approval for its Humira rheumatoid-arthritis drug earlier this week, expects the drug to see sales of more than $150 million globally in 2003 ...

An advisory panel for the Food and Drug Administration concluded Wednesday that Switzerland.-based Novartis AG’s version of Amgen’s arthritis drug Enbrel should be approved, according to Reuters. The ...